Introduction: Currently, routine radiotherapy (RT) planning for locally advanced lung cancer (LC) does not take into consideration the functional state of the lung. The goal of this study was to determine if it is technically feasible to integrate the sites of pulmonary emphysema (PE) into the RT planning process. Methods: Ten patients with LC and PE treated with helical Tomotherapy© were retrospectively included. After extraction by Myrian© software based on diagnostic CT (DCT), the PE data were transferred to the treatment planning system (TPS). PE-optimized plans were performed for patients with significant PE, where the dose was focused onto the PE. We compared the PE-optimized RT plans to the initial RT plans. Results: The median dose to the planning target volume (PTV) was 52 Gy (range, 36-66) in fractions of 2-3 Gy. The median PE volume was 220 cm
Introduction
Radiation therapy (RT) has a well-established role in the multidisciplinary approach of both early and locally advanced lung cancers (LC). Although surgery remains the standard treatment of early-stage lung cancer (LC), 1 inoperable patients can benefit from stereotactic radiotherapy treatments. This procedure gives good results in terms of local control and survival rate, with low toxicity. 2 For advanced-stage inoperable LC, conventionally fractionated radiation therapy (RT) with chemotherapy is considered standard of care. 3, 4 Several studies have investigated the effects of RT on lung function. [5] [6] [7] [8] It appears that expected pulmonary toxicity could lead to severe complications, particularly in LC, where patients often already have reduced lung function. Radiation pneumonitis is usually seen as the main dose-limiting factor that could lead to respiratory failure. 9 A four-dimensional planning computed tomography (CT) is standard for the preparation of a thoracic RT plan. Up until now, the dose received by functional lung areas has not been studied in RT plans as a dosimetric parameter. One of the most common tobacco-induced pulmonary lesions is pulmonary emphysema 10, 11 (PE), which corresponds to a destruction of the gas-exchanging tissues. 12 Therefore, it seems to be important to take these non-functional areas of the lung parenchyma into account, to limit the impact on the pulmonary reserve by RT. Using dedicated diagnostic imaging software, it is possible to process an automatic delineation of the areas of PE. This newly generated structure can then be transferred to the RT plan. The main goal of this dosimetric study is to show the possibility to transfer and integrate the PE information onto RT plans of patients treated for LC to reduce the dose delivered to the healthy lung (HL). 13 
Methods

Patients and target volumes
Criteria of selection were based on patients with LC (non-small cell LC or small cell LC) and PE treated with RT using intensity-modulated RT (IMRT) with helical Tomotherapy© (Accuray, Inc., Sunnyvale, CA, USA). Patients treated between February 2014 and October 2015 were retrospectively included. Preoperative, definitive and palliative treatments were included with or without concomitant chemotherapy; all patients received a RT dose superior to 30 Gy. Stereotactic treatments were excluded. All patients had a breath-hold diagnostic CT (DCT) before RT to confirm the presence of PE. For each patient, the gross tumour volume (GTV) was delineated on the RT planning CT and corresponded to the macroscopic tumour. All patients had three sets of dedicated CTs: a free breathing, a blocked end of inspiration and a blocked end of expiration CT. An internal target volume (ITV) was created using the maximal intensity projection method. The clinical target volume (CTV) was obtained by adding a 5-8 mm margin to the ITV, depending on the clinical situation. The planning target volume (PTV) corresponded to an expansion of 5 mm of the CTV.
PE structure
The PE structure was generated using Myrian© software (Intrasense Inc., Alins, France) based on a semi-automatic extraction of voxels below the threshold of À920 HU 14 on the diagnostic CT (Fig. 1 ). Once the PE structure was generated, the images were converted into exportable data and transferred as a structure to the contouring software, Velocity© AI (Varian Medical Systems, Inc., Palo Alto, CA, USA). For each eligible patient, a PE-optimized RT plan was performed if the PE volume represented more than 5% of the lung-PTV volume (Fig. 2 ). As this new structure was on the DCT, a deformable registration was performed using Velocity© to transfer it from the DCT to the RT planning CT. To create the healthy lung (HL) structure, the PE structure was smoothed using the Velocity© smoothing algorithm to obtain a homogenous volume. The HL structure was created, by excluding the PTV and the smooth-SPE structures of the lung volume.
(a) (b) Lung sparing using pulmonary emphysema
Organs at risk and constraints
The heart, oesophagus, lung minus PTV and the HL structures were considered as organs at risk. The constraints of quantitative analyses of normal tissue effects in the clinic (QUANTEC) for the lung and for the organs at risk [15] [16] [17] [18] were applied. Constraints for the lung were V5 < 60%, V20 < 30% and V30 < 20%. A mean dose <26 Gy for the heart and a mean dose <34 Gy for the oesophagus were required. New constraints were applied to the HL structure: V20 < 15% and V30 < 10%.
PE optimization planning
The objective of the PE optimization process was to avoid the HL by forcing the delivery beams to pass through the emphysematous regions. For each eligible patient for an optimized RT plan, a structure called protected lung (PL) was created. This structure, manually selected, corresponds to lung parenchyma without PE at the level of the PTV. The beam entrance was then blocked for the PL structure. Each case was recomputed with the same dose to the PTV, and the same constraints were applied to organs at risk. The optimization had to obtain the same PTV coverage, while respecting the usually adopted constraints for the 'lung minus PTV', despite the new constraints on the HL.
Plan comparison
The dose to the PTV and the organs at risk were compared for initial and PE-optimized RT plans. Values and percentages were computed for quantitative parameters. Student's t-test was used to show if the difference observed was statistically significant. P-values less than 0.05 were considered statistically significant.
Results
Patients and structures
One woman and nine men were included. The median age was 66 years (range: 57-73). The mean delay between DCT and RT dedicated CT was 32 days (range, 3-88). The median PE structure volume was 220 cm 3 (range:
12-1394). The proportion of PE represented on average 13% (range: 0-45%) of the lung minus PTV volume. Six patients had more than 5% of PE inside the lung-PTV volume and were eligible for a new RT plan. Specific results of eligible patients are presented in Table 1 . The median prescribed dose to the PTV was 52 Gy (range, 36-66) in fractions of 2-3 Gy.
Plan comparison
Planning target volume
The D98 decreased of 2 Gy on average between initial and PE-optimized plans, P < 0.05 (Table 2 ).
Lung minus PTV
The mean V20 and V30 were 16% and 9% on initial plans, and were 19% and 11% after PE optimization respectively. These differences were not significant (P > 0.05). For the V5, the mean value was 49% initially and 44% after PE optimization, and the difference was statistically significant (P < 0.05).
PE structure
The mean dose to the PE structure changed from 7 Gy (range, 0.7-14) to 9.8 Gy (range, 0.9-20), P < 0.05 (Table 2) .
Protected lung
The mean V5, V20 and V30 were, respectively, 94%, 33% and 17% before and decreased to 67%, 14% and 6% after re-planning. These differences were statistically significant, P < 0.05. 2  215  11  3490  2  66  2  1032  35  3262  3  66  2  1394  45  3934  4  36  3  271  13  2650  5  44  2  366  15  3846  6  44  2  223  5  4975 HL, healthy lung; PE, pulmonary emphysema. 
Healthy lung
The mean V20 and V30 were, respectively, 17% and 10% on initial plans, and were 19% and 12% after re-planning, P > 0.1 (Table 2 ). For V5, the mean value was 50% initially and 44% after re-planning, and the difference was statistically significant (P < 0.05). Results are presented in Table 2 .
Organs at risk
The mean heart dose raised from 5.1 to 6.1 Gy (P < 0.05), and the mean oesophagus dose increased from 14.2 to 18.4 Gy (P < 0.05).
Discussion
Although many LC patients also have considerable PE due to their history of smoking, the presence of these non-functional lung areas is not routinely taken into account in current RT planning practices. However, it is reasonable to extract non-functional parts of the lung and consider only the HL when evaluating the RT plan. By focusing RT treatments on pre-damaged areas, we may prevent damage inside the HL and, thus, limit the subsequent decrease in pulmonary functioning. The goal of this study was to determine the feasibility of protecting the non-PE lung during RT. In our original approach, we used a semi-automatic extraction of PE using a threshold technique with the Myrian© software to create a structure. We demonstrated that structures transfer from Myrian© to the contouring software is feasible. PE structure creation allowed us to create a set of structures that we used as organs at risk. We succeeded to modify the beam flow to increase the dose to the PE lung (P < 0.05) (Fig. 3) ; the V5 of the HL was significantly decreased but not the V30 and the V20 probably due to the small sample size. The dose to the organs at risk was increased, but never surpassed the QUANTEC limits.
It must be pointed out that the main goal was not to add constraints but to change the beam flow weight and avoid the non-PE lung without compromising the initial RT plan. To our knowledge, in the literature, there is no similar study that uses PE data to optimize RT lung plans. However, several studies have investigated the use of functional imaging in image-guided RT for LC. [19] [20] [21] [22] [23] In a prospective clinical trial, Siva et al. 19 studied the incorporation of 4D-ventilation/perfusion PET-CT in definitive RT plans. A highly perfused and highly ventilated lung structures were defined. After performing 80 RT plans in 20 patients they demonstrated that only the plans that were adapted to the perfused lung allowed for a dose reduction to the remaining functional lung. Christian et al. 20 evaluated the incorporation of lung perfusion by incorporating single photon emission computed tomography (SPECT) into inverse RT planning. The functioning lung structure corresponded to the most perfused areas. They found major differences in volume between whole lung and functioning lung. For one patient, a reduction of 16% of functioning lung receiving more than 20 Gy was observed. Lastly, Yamamoto et al. 21 used ventilation imaging based on the 4D CT method to optimize RT plans. They showed that CT ventilation functional imageguided treatment planning reduced the lung functional V20 by 5% compared to non-functional image-guided treatment.
All the above studies demonstrate that the use of functional imaging in RT plans for LC may reduce pulmonary toxicity. In our study, anatomical information was correlated with lung function since the emphysematous areas seen on the diagnostic CT are the parts of the lung without gas-exchange. One of the main advantages of our technique is it does not require an additional medical exam; a simple breathe-hold CT is sufficient to perform the PE extraction. This particular point is very important in regions of the world where some medical imaging techniques are not readily available. Previously described Fig. 3 . Radiotherapy plans in axial view for a pre-surgical case before (a) and after (b) PE optimization. The PTV is in blue, the PE is in dark blue and the PL is in beige.
functional imaging techniques might be helpful in creating treatment plans for patients with large perfusion deficits and help to estimate the deleterious effects of RT on lung perfusion. 24, 25 Perhaps these functional approaches could be combined with our approach to create a pre-RT pulmonary cartography. One of the biases of this study is that it was a dosimetric analysis based on a small number of patients. The goal of this work was mainly to evaluate the feasibility of the procedure. A prospective study with a larger cohort could help to demonstrate better preservation of lung function after RT by sparing the HL using our technique. Non-coplanar techniques that concentrate the beam on the most damaged lobe and completely avoid the HL could benefit from this technical approach.
In conclusion, the use of PE structures previously delineated with Myrian© software for treatment plan optimization is feasible. The difference between the HL and the lung minus PTV structures can be considerable. Focusing the beam flow on the PE structure when planning a RT treatment using helical Tomotherapy appears promising as a means of preserving pulmonary function following RT.
